The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive multi-omics analysis of BPM31510 in combination with gemcitabine in a phase 2 study of advanced pancreatic ductal adenocarcinoma (PDAC).
 
Madappa N. Kundranda
Consulting or Advisory Role - AstraZeneca; Bayer; BPG Bio; Bristol-Myers Squibb; Genomic Health; STERIS
Research Funding - Bayer (Inst); Celgene; Chronix Biomedical (Inst)
 
Can Bruce
Employment - BERG, LLC; BPGbio
Stock and Other Ownership Interests - BioNTech (I); Sage Therapeutics (I)
 
Elder Granger
Employment - The 5Ps; The 5Ps (I)
Leadership - Better Therapeutics; Cigna; Defense Logistics Health; Kaleo
Stock and Other Ownership Interests - Better Therapeutics; Cigna; Defense Logistics Health; Kaleo
Travel, Accommodations, Expenses - Better Therapeutics; Cigna; Defense Logistics Health; Kaleo
 
Brian Berman
Stock and Other Ownership Interests - Berg Pharma
Consulting or Advisory Role - Aiviva Biopharma; Almirall; Berg Pharma; BPG Bio; Lemonex; Mediwound; MINO Labs; Sensus; Sirnaomics; Sun Pharma; Thirona Biosciences
Speakers' Bureau - Almirall; Sensus
Research Funding - MINO Labs (Inst); Sirnaomics (Inst)
Travel, Accommodations, Expenses - Berg Pharma
 
Vijay Modur
Employment - BPGbio; Eloxx Pharmaceuticals
Leadership - BPBbio; Eloxx Pharmaceuticals
Stock and Other Ownership Interests - Eloxx Pharmaceuticals; Eloxx Pharmaceuticals; Eloxx Pharmaceuticals
Consulting or Advisory Role - BPGbio
 
Rangaprasad Sarangarajan
Employment - BPGBio
Leadership - BPGBio
Stock and Other Ownership Interests - BPGBio
Research Funding - BPGBio
Patents, Royalties, Other Intellectual Property - I am recipient of patent
Travel, Accommodations, Expenses - BPGBio
 
Anna A. Niewiarowska
Research Funding - Berg (Inst); Berg (Inst)
 
Lynne A. Bui
Employment - Khloris Biosciences
Leadership - Khloris Biosciences
Patents, Royalties, Other Intellectual Property - Khloris Biosciences
 
James Fredric Strauss
Employment - Dialectic Therapeutics
Leadership - Dialectic Therapeutics
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Bristol-Myers Squibb; Intuitive Surgical; Johnson & Johnson; Merck; Regeneron
Consulting or Advisory Role - Binhui Biopharmaceuticals, Ltd. (Inst); Synlogic (Inst)
 
Angela Tatiana Alistar
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; Merck
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Sant P. Chawla
Stock and Other Ownership Interests - AADi; Cellestia Biotech; Counterpoint; Immix BioPharma
Honoraria - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Karyopharm Therapeutics; NKMax; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma; Tyme
Consulting or Advisory Role - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Karyopharm Therapeutics; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Speakers' Bureau - Amgen; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; Janssen; Karyopharm Therapeutics; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Research Funding - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Janssen; Karyopharm Therapeutics; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
 
Roopinder Gillmore
Speakers' Bureau - Incyte
 
Manuel Hidalgo
Leadership - BMS
Stock and Other Ownership Interests - Champions Oncology; InxMed; Nelum Corp.
Honoraria - Champions Oncology; InxMed; MiNK Therapeutics; Oncomatrix
Consulting or Advisory Role - Fibrogen; InxMed; KAHR Medical; MiNK Therapeutics; Oncomatrix
Research Funding - Ranok Therapeutics; TopAl
Patents, Royalties, Other Intellectual Property - Royalties from Khar Medical for IP in cell therapy; Royalties from Myriad for PALB2 patent
Travel, Accommodations, Expenses - Agenus
 
Arianne Lyng
No Relationships to Disclose
 
Poornima Tekumalla
Employment - BPGbio
Leadership - BPGbio
Stock and Other Ownership Interests - Personal stock
Patents, Royalties, Other Intellectual Property - BPGbio Test to distinguish BPH and Prostate Cancer
Travel, Accommodations, Expenses - BPGbio
 
Greg M. Miller
Employment - Berg Pharma; Bluebird Bio (I); BPGbio; Nvelop Therapeutics (I)
Leadership - Nvelop Therapeutics (I)
Stock and Other Ownership Interests - Bluebird Bio (I)
 
Michael Kiebish
Employment - BPGbio
Stock and Other Ownership Interests - BPGbio
Patents, Royalties, Other Intellectual Property - Several patents on diagnostic biomarkers and therapeutic molecules owned by BERG Health
 
Niven R. Narain
Employment - BERG LLC; BPGbio Inc
Leadership - BERG LLC; BPGbio Inc
Stock and Other Ownership Interests - BERG LLC; BPGbio Inc
Research Funding - BERG LLC; BPGbio Inc
Patents, Royalties, Other Intellectual Property - Patents and other IP
Travel, Accommodations, Expenses - BERG LLC; BPGbio Inc
 
David Propper
Honoraria - Bayer; BPGbio
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Merck; Servier
Travel, Accommodations, Expenses - Celgene; Celgene
Other Relationship - Servier